Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer
- 30 June 2004
- Vol. 63 (6), 1138-1142
- https://doi.org/10.1016/j.urology.2004.01.040
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Long-term Followup of a Randomized Trial of 0 Versus 3 Months of Neoadjuvant Androgen Ablation Before Radical ProstatectomyJournal of Urology, 2003
- Comparison of the Efficacy of Local Therapies for Localized Prostate Cancer in the Prostate-Specific Antigen Era: A Large Single-Institution Experience With Radical Prostatectomy and External-Beam RadiotherapyJournal of Clinical Oncology, 2002
- Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancerUrology, 2001
- Neoadjuvant Chemotherapy and Hormonal Therapy Followed by Radical Prostatectomy: Feasibility and Preliminary ResultsJournal of Clinical Oncology, 2000
- CANCER RECURRENCE AND SURVIVAL RATES AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE CANCERJournal of Urology, 1998
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Altered β-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cellsBritish Journal of Cancer, 1998
- PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 1997
- Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.Journal of Clinical Oncology, 1996
- Neoadjuvant Hormonal Therapy Before Radical Prostatectomy Decreases the Number of Positive Surgical Margins in Stage T2 Prostate Cancer: Interim Results of a Prospective Randomized TrialJournal of Urology, 1995